TRANSLATE BIO, INC.

(TBIO)
End-of-day quote Nasdaq  -  2021-09-12
37.36 USD   -0.13%
2021TRANSLATE BIO, INC.(NASDAQGS : TBIO) dropped from S&P TMI Index
CI
2021TRANSLATE BIO, INC.(NASDAQGS : TBIO) dropped from S&P Global BMI Index
CI
2021TRANSLATE BIO, INC.(NASDAQGS : TBIO) dropped from S&P Biotechnology Select Industry Index
CI
SummaryQuotesChartsNewsRatingsCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Translate Bio : Roth Capital Adjusts Translate Bio's Price Target to $37 From $30, Maintains Buy Rating

12/22/2020 | 11:00am EDT


© MT Newswires 2020
All news about TRANSLATE BIO, INC.
2021TRANSLATE BIO, INC.(NASDAQGS : TBIO) dropped from S&P TMI Index
CI
2021TRANSLATE BIO, INC.(NASDAQGS : TBIO) dropped from S&P Global BMI Index
CI
2021TRANSLATE BIO, INC.(NASDAQGS : TBIO) dropped from S&P Biotechnology Select Industry Index
CI
2021TRANSLATE BIO : LifeSci Index Partners
AQ
2021INSIDER SELL : Translate Bio
MT
2021INSIDER SELL : Translate Bio
MT
2021INSIDER SELL : Translate Bio
MT
2021TRANSLATE BIO : Sanofi Completes Translate Bio Buyout
MT
2021TRANSLATE BIO, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delist..
AQ
2021TRANSLATE BIO, INC.(NASDAQGS : TBIO) dropped from NASDAQ Composite Index
CI
More news
Analyst Recommendations on TRANSLATE BIO, INC.
More recommendations
Chart TRANSLATE BIO, INC.
Duration : Period :
Translate Bio, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Michael Tolpa Treasurer
Jim Sullivan Senior Vice President-Pulmonary Discovery
Sector and Competitors
1st jan.Capi. (M$)
TRANSLATE BIO, INC.0.00%2 824
GILEAD SCIENCES, INC.-14.12%78 219
VERTEX PHARMACEUTICALS30.84%73 484
REGENERON PHARMACEUTICALS, INC.-5.72%64 152
WUXI APPTEC CO., LTD.-13.31%44 566
BIONTECH SE-38.91%38 276